Board meeting to approve September 2026 quarterly results

Results View source PDF Explain this filing

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+7.3%Reaction day

₹2041.00

prior close

₹2106.10

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.7%+5.6% vs market

Pharmaceuticals peers, median of 173sector+2.0%+5.3% vs sector

On the reaction day the stock moved 5.6 pts more than Nifty Microcap 250 and 5.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

-0.3

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+7.3+1.7+5.6+2.0+5.3

Next day

+9.4pendingpending+2.6+6.7

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Hester Biosciences has scheduled a Board meeting for 5 November 2026 to consider and approve its unaudited standalone and consolidated financial results for the quarter and six months ended 30 September 2026. No financial figures are provided yet.

Likely market impact

This announcement only confirms the results date. Share prices may react once the September 2026 financial performance is published.